Limitations, agreements, and source contact

Afatinib in Advanced Refractory Urothelial Cancer · Source last updated 2025-04-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

podonnel@bsd.uchicago.edu

organization

University of Chicago

phone

(773) 702-7564

title

Dr. Peter O'Donnell

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice